Maintained Hematologic and Organ Responses Following Risk Adapted Stem Cell Transplant (SCT) in Systemic Light-Chain Amyloidosis (AL) Using Bortezomib and Dexamethasone as Consolidation Therapy
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2011.12.011
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2012
Authors
Publisher
Elsevier BV